![](https://nta.org/wp-content/uploads/2023/07/img-banner-opportunities-1200px.webp)
NTA provides a curated pipeline of vetted opportunities aligned with industry and national priorities. We are continuously consolidating new opportunities from Catalyst Partners, government requirements, and industry targets. Contact us to share your opportunities with NTA’s diverse community or organizations. Join NTA today to receive email notifications.
Upcoming
![Accelerated Antibodies Modification](https://nta.org/wp-content/uploads/2024/07/MCDC_-NTA-Page_Accelerated-Antibodies-Modification-1-1024x770.webp)
Accelerated Antibodies Modification
Anticipated Release Date: Q3FY24: Modification of existing Accelerated Antibodies agreement for additional monoclonal antibody prototype. Responding to this opportunity requires …
![Agent Directed Therapeutic (ADTX) FY25 OTA](https://nta.org/wp-content/uploads/2024/07/Agent-Directed-Therapeutic-ADTX-FY25-OTA-1024x770.webp)
Agent Directed Therapeutic (ADTX) FY25 OTA
Anticipated Release Date: Q1FY25 New start OTA award for ADTX Responding to this opportunity requires membership in the Countering Weapons …
![Autonomous Decontamination System (ADS) / PPMT](https://nta.org/wp-content/uploads/2024/04/CWMD_NTA-Page-652x490_Autonomous-Decontamination-System-ADS-_-PPMT-TBD-1024x770.webp)
Autonomous Decontamination System (ADS) / PPMT
Anticipated Release Date: Q1FY25 The Autonomous Decontamination System program will provide a semi-autonomous supported capability that relies on precision detection …
![Aviation Universal Charger](https://nta.org/wp-content/uploads/2024/07/NTA-Page-EMC-652x4909-1-1024x770.webp)
Aviation Universal Charger
Anticipated Release Date: 8/13/2024 A three phased approach is preferred. The first phase takes the project through preliminary design review …
![Capabilities and Needs for Future Respiratory and Ocular Protection Systems](https://nta.org/wp-content/uploads/2024/07/Capabilities-and-Needs-for-Future-Respiratory-and-Ocular-Protection-Systems-1024x770.webp)
Capabilities and Needs for Future Respiratory and Ocular Protection Systems
Anticipated Release Date: Q3FY25 This topic aims to provide novel, low-burden masks for the general purpose warfighter utilizing innovative materials …
![ChemDx Expansion](https://nta.org/wp-content/uploads/2024/04/MCDC_-NTA-Page_ChemDx-Expansion-1024x770.webp)
ChemDx Expansion
Anticipated Release Date: Q3FY24 Develop a diagnostic prototype strip, compatible with the ChemDx device, able to diagnose opioid exposure. Additional …
![Consolidated Nerve Agent Treatment System](https://nta.org/wp-content/uploads/2024/04/MCDC_-NTA-Page_Consolidated-Nerve-Agent-Treatment-System-1024x770.webp)
Consolidated Nerve Agent Treatment System
Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability …
![Development of alternate large animal models for biothreats (viral and toxin) and chemical threats](https://nta.org/wp-content/uploads/2024/07/Development-of-alternate-large-animal-models-for-biothreats-viral-and-toxin-and-chemical-threats-1024x770.webp)
Development of alternate large animal models for biothreats (viral and toxin) and chemical threats
Anticipated Release Date: Q4FY24 Development of alternate large animal models for biothreats (viral and toxin) and chemical threats. Due to …
![Development of Novel, Broad Spectrum Countermeasures, and enabling capabilities for Toxin Exposure](https://nta.org/wp-content/uploads/2024/07/Development-of-Novel-Broad-Spectrum-Countermeasures-and-enabling-capabilities-for-Toxin-Exposure-1024x770.webp)
Development of Novel, Broad Spectrum Countermeasures, and enabling capabilities for Toxin Exposure
Anticipated Release Date: Q4FY24 Prophylactic and therapeutic medical countermeasures for exposure to naturally occurring, synthetic and/or aerosolized toxins (excluding botulinum …
![Diagnostic Platforms for Agnostictoxin Detections](https://nta.org/wp-content/uploads/2024/07/CWMD_NTA-Page-652x490_9-1024x770.webp)
Diagnostic Platforms for Agnostictoxin Detections
Anticipated Release Date: Q2FY25 Develop diagnostic and detection assays, platforms, or devices to sense exposures of emerging toxins, to include …
![IEW Phase 2](https://nta.org/wp-content/uploads/2024/04/CWMD_NTA-Page-652x490_EW-Phase-2-_-TBD-1024x770.webp)
IEW Phase 2
Anticipated Release Date: Q2FY24 Establish Mission Planning and integration of the tactical, operational, Network convergence and CI/CD pipeline. This will …
![Mature Microphysiological System To Directly Compare To Well-Characterized Animal Model Results](https://nta.org/wp-content/uploads/2024/07/MCDC_-NTA-Page_8-1024x770.webp)
Mature Microphysiological System To Directly Compare To Well-Characterized Animal Model Results
Anticipated Release Date: Q4FY24 Develop a microphysiological system that realistically mimics human physiological responses to threat exposures for rapid discovery …
![Microphysiological Systems To Expand Diagnostic Capabilities](https://nta.org/wp-content/uploads/2024/04/MCDC_-NTA-Page_Microphysiological-systems-to-expand-diagnostic-capabilities-1024x770.webp)
Microphysiological Systems To Expand Diagnostic Capabilities
Anticipated Release Date: Q2FY24 Develop a microphysiological system that realistically mimics human physiological responses to threat exposures for rapid discovery …
![Novel and Cross Domain Uncrewed Systems](https://nta.org/wp-content/uploads/2024/04/Novel-and-Cross-Domain-Uncrewed-Systems_NTA-Page-EMC-652x490_-1024x770.webp)
Novel and Cross Domain Uncrewed Systems
Anticipated Release Date: April, 15 2024 NSWC – Crane is seeking novel air and maritime UXS to perform in a …
![Novelbioaerosol Detection and Identification Technologies](https://nta.org/wp-content/uploads/2024/04/CWMD_NTA-Page-652x490_Novelbioaerosol-detection-and-identification-technologies-1024x770.webp)
Novelbioaerosol Detection and Identification Technologies
Anticipated Release Date: Q2FY24 Novel approaches to bioaerosol detection and identification that implement reliable, accurate and timely sampling mechanisms in …
![Portable Patient Transport System -Enhanced Biodefense (PPTS-ENBD) / PPMT](https://nta.org/wp-content/uploads/2024/04/CWMD_NTA-Page-652x490_Portable-Patient-Transport-System-Enhanced-Biodefense-PPTS-ENBD-_-PPMT-TBD-1024x770.webp)
Portable Patient Transport System -Enhanced Biodefense (PPTS-ENBD) / PPMT
Anticipated Release Date: Q4FY24 The Portable Patient Transport System Enhanced Biodefense (PPTS ENBD) is a patient transport system that enables …
![Prototype MCMs to address the therapeutic indications of the Warfighter exposure to viral and bacterial biothreat agents](https://nta.org/wp-content/uploads/2024/07/Prototype-MCMs-to-address-the-therapeutic-indications-of-the-Warfighter-exposure-to-viral-and-bacterial-biothreat-agents-1024x770.webp)
Prototype MCMs to address the therapeutic indications of the Warfighter exposure to viral and bacterial biothreat agents
Anticipated Release Date: Q4FY24 The prioritizations on broad-spectrum direct-acting antivirals (nucleoside/nucleotide-like compounds and combination therapies) and host-directed broad-spectrum antivirals and …
![Shipboard Isolation System (SIS) / PPMT](https://nta.org/wp-content/uploads/2024/04/CWMD_NTA-Page-652x490_Shipboard-Isolation-System-SIS-_-PPMT-TBD-1024x770.webp)
Shipboard Isolation System (SIS) / PPMT
Anticipated Release Date: Q4FY24 The SIS program provides the capability to temporarily isolate or quarantine personnel to prevent the spread …
![Small Molecule Therapeutics](https://nta.org/wp-content/uploads/2024/04/MCDC_-NTA-Page_Small-Molecule-Therapeutics-1024x770.webp)
Small Molecule Therapeutics
Anticipated Release Date: Q1FY24 OR Q2FY24 Small Molecule Therapeutics Responding to this opportunity requires membership in the Medical CBRN Defense …
![Systems Integrating iNnovativeSolutions To Enable Rapid detection (SINISTER)](https://nta.org/wp-content/uploads/2024/04/CWMD_NTA-Page-652x490_Systems-Integrating-iNnovativeSolutions-To-Enable-Rapid-detection-SINISTER-1024x770.webp)
Systems Integrating iNnovativeSolutions To Enable Rapid detection (SINISTER)
Release Date: TBD Develop novel multi-functional detection indicator technology for vapor and aerosol hazards aimed at decreasing burden via easy-to-use …
![Therapeutics Capability Area](https://nta.org/wp-content/uploads/2024/04/MCDC_-NTA-Page_-Therapeutics-Capability-Area-1024x770.webp)
Therapeutics Capability Area
Anticipated Release Date: Q3FY24 OR Q4FY24 Multiple Topics TBD—Possible 3 or 4 The goal of the Therapeutics Capability Area is …
![Vaccines Capability Area](https://nta.org/wp-content/uploads/2024/04/MCDC_-NTA-Page_Vaccines-Capability-Area-1024x770.webp)
Vaccines Capability Area
Anticipated Release Date: Q3FY24 OR Q4FY24 Multiple Topics TBD—Possible 3 or 4 The goal of the Vaccines Capability Area is …
![VaporAgent Demasking –Easily Readable](https://nta.org/wp-content/uploads/2024/04/CWMD_NTA-Page-652x490_VaporAgent-Demasking-–Easily-Readable-1024x770.webp)
VaporAgent Demasking –Easily Readable
VaporAgent Demasking –Easily Readable Develop low-burden, low-cost detection capabilities for chemical threat vapors to facilitate doffing PPE as part of …
Active
![2024-07 Developmental Sciences Funding Opportunity](https://nta.org/wp-content/uploads/2024/04/NTA-Opportunities-652x490_6-2-1024x770.webp)
2024-07 Developmental Sciences Funding Opportunity
Due: July 30, 2024 Developmental Sciences supports basic research that increases our understanding of perceptual, cognitive, linguistic, social, cultural, and …
![2024-07 Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_22-1024x770.webp)
2024-07 Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders
Due: July 26, 2024 The goal is to leverage AI/ML tools to identify pharmacotherapeutic development candidates with lower toxicity and …
![2024-07 ML/AI Tools to Advance Genomic Translational Research (MAGen)](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_23-1024x770.webp)
2024-07 ML/AI Tools to Advance Genomic Translational Research (MAGen)
Due: July 28, 2024 The National Human Genome Research Institute aims to setup a research Consortium, ML/AI Tools to Advance …
![2024-07 Quantum Information Science Enabled Discovery](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_24-1024x770.webp)
2024-07 Quantum Information Science Enabled Discovery
Due: July 30, 2024 he DOE SC program in High Energy Physics (HEP) hereby announces its interest in receiving interdisciplinary …
![2024-07 Remote Weapons System (RWS)/Fire Control System (FCS) Maturation and Integration for Hard Kill (HK) Active Protection System (APS)](https://nta.org/wp-content/uploads/2024/04/NTA_TREX-new-652x490_-1024x770.webp)
2024-07 Remote Weapons System (RWS)/Fire Control System (FCS) Maturation and Integration for Hard Kill (HK) Active Protection System (APS)
Due: July 29, 2024 Remote Weapons System (RWS)/Fire Control System (FCS) Maturation and Integration for Hard Kill (HK) Active Protection …
![2024-07 RFS MSH-24 Measuring Sexual Harassment in the Science Technology Education and Mathematics](https://nta.org/wp-content/uploads/2024/07/NTA-Page-ADC-652x49017-1-1024x770.webp)
2024-07 RFS MSH-24 Measuring Sexual Harassment in the Science Technology Education and Mathematics
Due: July 29, 2024 The objective of this study is to implement some of what was learned in Phase 1 …
![2024-08 Advancements in Radiation Detection Hardware and Software](https://nta.org/wp-content/uploads/2024/07/CWMD_NTA-Page-652x490_10-1-1024x770.webp)
2024-08 Advancements in Radiation Detection Hardware and Software
Due: August 19, 2024 The Defense Threat Reduction Agency Research and Development (DTRA-RD) Directorate, Nuclear Detection Division (NTD) develops and …
![2024-08 Advancing HIV service delivery through pharmacies and pharmacists](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_29-1024x770.webp)
2024-08 Advancing HIV service delivery through pharmacies and pharmacists
Due: August 13, 2024 The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, …
![2024-08 Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders](https://nta.org/wp-content/uploads/2024/03/NTA-Opportunities-652x490_79-1024x770.webp)
2024-08 Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders
Due: August 13, 2024 The goal of this initiative is to support research aimed at (1) identification of targets and …
![2024-08 COmpact Front-end Filters at the ElEment-level (COFFEE) Program](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_25-1024x770.webp)
2024-08 COmpact Front-end Filters at the ElEment-level (COFFEE) Program
Due: August 2, 2024 The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals that demonstrate integration of technology …
![2024-08 Correctness for Scientific Computing Systems](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_28-1024x770.webp)
2024-08 Correctness for Scientific Computing Systems
Due: August 13, 2024 Correctness for Scientific Computing Systems (CS2) is a joint program of the National Science Foundation (NSF) …
![2024-08 DoD Prostate Cancer, Implementation Science Award](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_31-1024x770.webp)
2024-08 DoD Prostate Cancer, Implementation Science Award
Due: August 30, 2024 Research supported by the Implementation Science Award is expected to have the potential for major, near-term …
![2024-08 DoD, Melanoma, Focused Program Award - Rare Melanomas](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_30-1024x770.webp)
2024-08 DoD, Melanoma, Focused Program Award – Rare Melanomas
Due: August 26, 2024 FPA-RM applications must describe a unifying, overarching question that will be investigated by a set of …
![2024-08 ECosystem for Leading Innovation in Plasma Science and Engineering](https://nta.org/wp-content/uploads/2024/03/NTA-Opportunities-652x490_70-1024x770.webp)
2024-08 ECosystem for Leading Innovation in Plasma Science and Engineering
Due: August 13, 2024 The primary goal of the ECosystem for LeadingInnovation inPlasmaScience andEngineering (ECLIPSE) program is to identify and …
![2024-08 Mechanistic Studies on Social Behavior in Substance Use Disorder](https://nta.org/wp-content/uploads/2024/04/NTA-Opportunities-652x490_29-1-1024x770.webp)
2024-08 Mechanistic Studies on Social Behavior in Substance Use Disorder
Due: August 14, 2024 The purpose of this notice of funding opportunity (NOFO) is to solicit applications proposing innovative transdisciplinary …
![2024-08 NEI Research for Low Vision and Blindness Accessibility Tools](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_27-1024x770.webp)
2024-08 NEI Research for Low Vision and Blindness Accessibility Tools
Due: August 13, 2024 The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate translational efforts in developing …
![2024-08 Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_26-1024x770.webp)
2024-08 Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers
Due: August 3, 2024 The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for Senator Paul …
![2024-08 TREXII Digital OnRamp Platform](https://nta.org/wp-content/uploads/2024/07/NTA_TREX-new-652x490_6-1024x770.webp)
2024-08 TREXII Digital OnRamp Platform
Due: September 9, 2024 The desired objective is to provide private sector and government with a secure, scaled, and efficient …
![2024-09 RWP-OA-24-01 Critical Sectors](https://nta.org/wp-content/uploads/2024/05/NTA-Page-DBIC-652x490_2024-09-White-Papers-For-Defense-Production-Act-Title-III-and-Industrial-Base-Analysis-and-Sustainment-300x225.webp)
2024-09 RWP-OA-24-01 Critical Sectors
Due: September 30, 2024 The Defense Industrial Base Consortium (DIBC) is excited to release the Open Announcement OA-24-01, which is …
![2024-09 Biodiversity on a Changing Planet](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_32-1024x770.webp)
2024-09 Biodiversity on a Changing Planet
Due: September 5, 2024 The Biodiversity on a Changing Planetprogram is a cross-directorate and international program led by NSF that …
![2024-09 Capital Readiness Program](https://nta.org/wp-content/uploads/2024/07/1207861395752755.evNaKog456WCa7nftxJy_height640.png)
2024-09 Capital Readiness Program
Due: September 27, 2024 This 5-day boot camp prepares medtech, digital health, and healthcare technology startups to raise their first …
![2024-09 DoD Peer Reviewed Orthopaedic, Clinical Translational Research Award](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_34-1024x770.webp)
2024-09 DoD Peer Reviewed Orthopaedic, Clinical Translational Research Award
Due: September 17, 2024 Orthopaedic injuries have a profound impact on military readiness and return to work/activity/duty. In the military, …
![2024-09 FY2024 CHIPS Manufacturing USA Institute Competition](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_33-1024x770.webp)
2024-09 FY2024 CHIPS Manufacturing USA Institute Competition
Due: September 9, 2024 This NOFO seeks proposals from eligible applicants for activities to establish and operate a CHIPS Manufacturing …
![2024-09 Smart Cities - Smart Bases Innovation Challenge](https://nta.org/wp-content/uploads/2024/07/NTA-Smart-Bases-Innovation-Challenge_-copy-2-1024x770.webp)
2024-09 Smart Cities – Smart Bases Innovation Challenge
Due: September 3, 2023 The Smart Cities – Smart Bases Innovation Challenge wants to know how YOU can deliver cutting-edge, …
![2024-10 Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias](https://nta.org/wp-content/uploads/2024/04/NTA-Opportunities-652x490_5-2-1024x770.webp)
2024-10 Development and Validation of Human Cellular Models for Alzheimer’s Disease-Related Dementias
Due: October 21, 2024 This NOFO would support development and validation of novel clinically- and/or pathophysiologically-relevant human cellular models of …
![2024-10 DoD Traumatic Brain Injury and Psychological Health, Focused Program Award](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_35-1024x770.webp)
2024-10 DoD Traumatic Brain Injury and Psychological Health, Focused Program Award
Due: October 3, 2024 The intent of the FY24 TBIPHRP FPA is to accelerate the development of solutions to critical …
![2024-10 xTechHBCU Student 2024-2025](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_36-1024x770.webp)
2024-10 xTechHBCU Student 2024-2025
Due: October 30, 2024 The U.S. Army invites Historically Black Colleges and Universities students to participate in xTechHBCU Student — …
![2024-11 Specialized Alcohol Research Centers](https://nta.org/wp-content/uploads/2024/06/NTA-Page-652x490_37-1024x770.webp)
2024-11 Specialized Alcohol Research Centers
Due: November 15, 2024 This Notice of Funding Opportunity (NOFO) invites applications for specialized Alcohol Research Centers using the P50 …
![2025-06 Industrialization and Translation of Extracellular Vesicles For Use In Regenerative Medicine](https://nta.org/wp-content/uploads/2023/08/NTA-Opportunities-Webp-652x490_75.webp)
2025-06 Industrialization and Translation of Extracellular Vesicles For Use In Regenerative Medicine
DUE: June 7, 2025 STTR Opportunity: Supporting the development of extracellular vesicle technologies for regenerative medical applications APPLY …
![2025-06 Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)](https://nta.org/wp-content/uploads/2023/08/NTA-Opportunities-Webp-652x490_74.webp)
2025-06 Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
DUE: June 25, 2025 SBIR Opportunity: Supporting the development of extracellular vesicle technologies for regenerative medical applications. APPLY …
![2026-07 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products](https://nta.org/wp-content/uploads/2024/04/NTA-Opportunities-652x490_25-1-1024x770.webp)
2026-07 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products
Due: July 14, 2026 This Notice of Funding Opportunity (NOFO) encourages cooperative agreement applications for investigator-initiated, multi-site, clinical trials (Phase …
![2026-09 Grant Opportunity: Assay development and screening for discovery of chemical probes, drugs or immunomodulators](https://nta.org/wp-content/uploads/2023/10/NTA-Opportunities-Webp-652x490_16-3-1024x770.webp)
2026-09 Grant Opportunity: Assay development and screening for discovery of chemical probes, drugs or immunomodulators
DUE: September 7, 2026 Seeking applications for identification of small molecules that function to elucidate the biology of disease as …
![2026-09 Grant Opportunity: Research Projects to Enhance Applicability of Mammalian Models for Translational Research](https://nta.org/wp-content/uploads/2023/10/NTA-Opportunities-Webp-652x490_10-1-1024x770.webp)
2026-09 Grant Opportunity: Research Projects to Enhance Applicability of Mammalian Models for Translational Research
DUE: September 7, 2026 The National Cancer Institute invites applications for projects to expand, improve, or transform the utility of …
![2026-11 Grant Opportunity: Personal Health Informatics for Delivering Actionable Insights to Individuals](https://nta.org/wp-content/uploads/2023/10/NTA-Opportunities-Webp-652x490_17-2-1024x770.webp)
2026-11 Grant Opportunity: Personal Health Informatics for Delivering Actionable Insights to Individuals
DUE: November 5, 2026 Furthering the science of personal health informatics by providing meaningful and actionable insights to individuals through …
![2027-01 Grant Opportunity: Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics](https://nta.org/wp-content/uploads/2023/10/NTA-Opportunities-Webp-652x490_4-1-1024x770.webp)
2027-01 Grant Opportunity: Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics
DUE: January 7, 2027 Funding available to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics …
![2028-08 Grant Opportunity: Improving Diagnostic Safety in Ambulatory Care](https://nta.org/wp-content/uploads/2023/10/NTA-Opportunities-Webp-652x490_7-1-1024x770.webp)
2028-08 Grant Opportunity: Improving Diagnostic Safety in Ambulatory Care
DUE: August 31, 2028 Funding opportunity to develop strategies and interventions to improve diagnostic safety in the heterogenous ambulatory care …
![2029-10 AHRQ Health Services Research Projects](https://nta.org/wp-content/uploads/2024/04/NTA-Opportunities-652x490_20-1-1024x770.webp)
2029-10 AHRQ Health Services Research Projects
Due: October 6, 2029 The purpose of this Notice of Funding Opportunity (NOFO) is to seek health services research grant …